Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (3): 377-385.doi: 10.19982/j.issn.1000-6621.20250381
• Original Articles • Previous Articles Next Articles
Gu Yuhong, Liu Zengwei(
), Wu Xiaoying, He Liqian, Zhang Yahui, Wu Guifeng
Received:2025-09-19
Online:2026-03-10
Published:2026-03-06
Contact:
Liu Zengwei
E-mail:2005131032@163.com
Supported by:CLC Number:
Gu Yuhong, Liu Zengwei, Wu Xiaoying, He Liqian, Zhang Yahui, Wu Guifeng. Analysis of the screening effectiveness and influencing factors of tuberculin skin test and interferon-gamma release assays for close contacts in schools: A retrospective real-world study[J]. Chinese Journal of Antituberculosis, 2026, 48(3): 377-385. doi: 10.19982/j.issn.1000-6621.20250381
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250381
| 特征 | TST组(2714名) | IGRA组(4179名) | 统计检验值 | P值 |
|---|---|---|---|---|
| 性别[例(构成比,%)] | χ2=33.636 | <0.001 | ||
| 男性 | 1192(43.92) | 2134(51.08) | ||
| 女性 | 1522(56.08) | 2045(48.92) | ||
| 年龄[岁,M(Q1,Q3)] | 17.00(14.00,21.00) | 18.00(15.00,21.00) | Z=-4.244 | <0.001 |
| 学校类型[例(构成比,%)] | χ2=279.520 | <0.001 | ||
| 幼儿园及小学 | 253(9.32) | 307(7.35) | ||
| 初高中 | 1175(43.29) | 2157(51.61) | ||
| 职业学校 | 746(27.49) | 524(12.54) | ||
| 大学 | 540(19.90) | 1191(28.50) | ||
| 接触者身份[例(构成比,%)] | χ2=9.464 | 0.002 | ||
| 学生 | 2417(89.06) | 3617(86.55) | ||
| 教职工 | 297(10.94) | 562(13.45) | ||
| 指示病例病原学结果[例(构成比,%)] | χ2=554.767 | <0.001 | ||
| 阳性 | 1406(51.81) | 3295(78.85) | ||
| 阴性 | 1308(48.19) | 884(21.15) | ||
| 指示病例身份[例(构成比,%)] | χ2=131.975 | <0.001 | ||
| 学生 | 2249(82.87) | 3287(78.66) | ||
| 教师 | 459(16.91) | 672(16.08) | ||
| 其他职工 | 6(0.22) | 220(5.26) | ||
| 合计 | 2714(39.37) | 4179(60.63) | χ2=311.360 | <0.001 |
| 特征 | TST组(2714例/名) | IGRA组(4179例/名) | ||||||
|---|---|---|---|---|---|---|---|---|
| 阳性 | 阴性 | 统计检验值 | P值 | 阳性 | 阴性 | 统计检验值 | P值 | |
| 性别 | χ2=23.708 | <0.001 | χ2=0.278 | 0.598 | ||||
| 女性 | 397(26.08) | 1125(73.92) | 175(8.56) | 1870(91.44) | ||||
| 男性 | 217(18.21) | 975(81.79) | 173(8.11) | 1961(91.89) | ||||
| 年龄(岁) | 19.00 (17.00,22.00) | 17.00 (14.00,20.00) | Z=-10.543 | <0.001 | 18.00 (17.00,30.00) | 18.00 (15.00,21.00) | Z=-6.970 | <0.001 |
| 接触者身份 | χ2=64.879 | <0.001 | χ2=62.566 | <0.001 | ||||
| 学生 | 492(20.36) | 1901(79.64) | 253(6.99) | 3364(93.01) | ||||
| 教职工 | 122(41.08) | 175(58.92) | 95(16.90) | 467(83.10) | ||||
| 指示病例身份 | χ2=0.836 | 0.658 | χ2=9.153 | 0.010 | ||||
| 学生 | 516(22.94) | 1733(77.06) | 294(8.94) | 2993(91.06) | ||||
| 教师 | 97(21.13) | 362(78.87) | 45(6.70) | 627(93.30) | ||||
| 其他职工 | 1(1/6) | 5(5/6) | 9(4.09) | 211(95.91) | ||||
| 指示病例病原学结果 | χ2=0.141 | 0.708 | χ2=5.831 | 0.016 | ||||
| 阴性 | 300(22.94) | 1008(77.06) | 56(6.33) | 828(93.67) | ||||
| 阳性 | 314(22.33) | 1092(77.67) | 292(8.86) | 3003(91.14) | ||||
| 学校类型 | χ2=35.189 | <0.001 | χ2=43.181 | <0.001 | ||||
| 小学及幼儿园 | 39(15.42) | 214(84.58) | 17(5.54) | 290(94.46) | ||||
| 初高中 | 231(19.66) | 944(80.34) | 228(10.57) | 1929(89.43) | ||||
| 职业学校 | 177(23.73) | 569(76.27) | 51(9.73) | 473(90.27) | ||||
| 大学 | 167(30.93) | 373(69.07) | 52(4.37) | 1139(95.63) | ||||
| 变量 | TST阳性率(%) | IGRA阳性率(%) | aOR值 | 95%CI值 | P值 |
|---|---|---|---|---|---|
| 合计 | 21.74 | 7.04 | 0.292 | 0.250~0.341 | <0.001 |
| 年龄a | 19.00 | 18.00 | 1.067 | 1.050~1.084 | <0.001 |
| 性别 | |||||
| 女性 | 26.08 | 8.56 | 1.000 | - | - |
| 男性 | 18.21 | 8.11 | 1.273 | 1.100~1.473 | 0.001 |
| 接触者身份 | |||||
| 学生 | 20.36 | 6.99 | 1.000 | - | - |
| 教职工 | 41.08 | 16.90 | 0.556 | 0.350~0.883 | 0.013 |
| 指示病例身份 | 0.053 | ||||
| 学生 | 22.94 | 8.94 | 1.000 | - | - |
| 教师 | 21.13 | 6.70 | 0.935 | 0.751~1.165 | 0.550 |
| 其他职工 | 16.67 | 4.09 | 0.405 | 0.194~0.848 | 0.016 |
| 指示病例病原学结果 | |||||
| 阴性 | 22.94 | 6.33 | 1.000 | - | - |
| 阳性 | 22.33 | 8.86 | 1.050 | 0.894~1.234 | 0.552 |
| 学校类型 | 0.020 | ||||
| 小学及幼儿园 | 15.42 | 5.54 | 1.000 | - | - |
| 初高中 | 19.66 | 10.57 | 0.941 | 0.643~1.378 | 0.755 |
| 职业学校 | 23.73 | 9.73 | 0.803 | 0.543~1.187 | 0.272 |
| 大学 | 30.93 | 4.37 | 1.097 | 0.773~1.556 | 0.604 |
| [1] | World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization, 2025. |
| [2] | Cohen A, Mathiasen VD, Schön T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2019, 54(3):1900655. doi:10.1183/13993003.00655-2019. |
| [3] | Rao M, Ippolito G, Mfinanga S, et al. Latent TB Infection (LTBI)-Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis, 2019, 80S: S58-S61. doi:10.1016/j.ijid.2019.02.035. |
| [4] |
Chee CBE, Reves R, Zhang Y, et al. Latent tuberculosis infection: Opportunities and challenges. Respirology, 2018, 23(10):893-900. doi:10.1111/resp.13346.
URL pmid: 29901251 |
| [5] | 马艳, 陆伟, 高磊, 等. 终止结核病流行须加强结核分枝杆菌潜伏感染高危人群筛查和预防性治疗的管理. 中国防痨杂志, 2022, 44(3): 209-214. doi:10.19982/j.issn.1000-6621.20220008. |
| [6] |
Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2011, 37(1):100-111. doi:10.1183/09031936.00114810.
URL pmid: 20847080 |
| [7] | Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev, 2014, 27(1):3-20. doi:10.1128/CMR.00034-13. |
| [8] | 中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家教育部办公厅. 关于印发中国学校结核病防控指南(2020年版)的通知. 国卫办疾控函〔2020〕910号.2020-10-16. |
| [9] | 中国防痨协会. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识. 中国防痨杂志, 2021, 43(9):874-878. doi:10.3969/j.issn.1000-6621.2021.09.004. |
| [10] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5 (4): 376-378. doi:10.19983/j.issn.2096-8493.2024022. |
| [11] | 国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
| [12] | Shrestha AB, Siam IS, Tasnim J, et al. Prevalence of latent tuberculosis infection in Asian nations: A systematic review and meta-analysis. Immun Inflamm Dis, 2024, 12(2):e1200. doi:10.1002/iid3.1200. |
| [13] | World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018. |
| [14] |
Campbell JR, Krot J, Elwood K, et al. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants. Mol Diagn Ther, 2015, 19(1):9-24. doi:10.1007/s40291-014-0125-0.
URL pmid: 25579159 |
| [15] |
Pang Y, Kang W, Zhao A, et al. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China. Vaccine, 2015, 33(1):209-213. doi:10.1016/j.vaccine.2014.10.086.
URL pmid: 25454854 |
| [16] | World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva: World Health Organization, 2015. |
| [17] | 董小伟, 郭卉欣, 张晨晨, 等. 结核分枝杆菌感染检测两步法在学校结核病筛查中的应用价值. 中国防痨杂志, 2022, 44(8):802-807. doi:10.19982/j.issn.1000-6621.20220096. |
| [18] |
Kowada A, Takasaki J, Kobayashi N. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries. J Hosp Infect, 2015, 89(2):99-108. doi:10.1016/j.jhin.2014.10.006.
URL pmid: 25559158 |
| [19] |
Schepisi MS, Motta I, Dore S, et al. Tuberculosis transmission among children and adolescents in schools and other congregate settings: a systematic review. New Microbiol, 2019, 41(4):282-290.
pmid: 30252926 |
| [20] | Campbell JR, Winters N, Menzies D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ, 2020, 368:m549. doi:10.1136/bmj.m549. |
| [21] | World Health Organization. WHO consolidated guidelines on tuberculosis: Module 1: Prevention-Tuberculosis preventive treatment, second edition. Geneva: World Health Organization, 2024. |
| [1] | Shu Wei, Liu Yuhong. Interpretation of research and innovation part of the WHO Global Tuberculosis Report 2025 [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 307-312. |
| [2] | Wang Jing, Jing Wei, Li Weiwen, Zhu Qingdong, Pang Yu, Chu Naihui, Nie Wenjuan. Clinical cohort analysis of the efficacy and safety of extended-course bedaquiline in patients with multidrug-resistant/rifampicin-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 313-319. |
| [3] | Zhang Yujie, Zhou Jie, Wang Yun, Fan Lin. Evaluation of diagnostic value of novel blood-derived biomarkers for active pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 320-328. |
| [4] | Hou Tianyong, Ren Liping, Li Jingying, Wang Jianwei, Fan Shuhui, Wu Yuanming, Wang Quanhong, Ding Weimin. Clinical application value of combined molecular biology testing with bronchoalveolar lavage fluid (BALF) for diagnosing smear-negative pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 329-334. |
| [5] | Zhu Qingdong, Zhao Chunyan, Huang Xuewen, Huang Aichun, Zeng Chunmei, Xu Chaoyan, Lan Yanqun, Song Chang. The application value of nanopore sequencing in the diagnosis of tuberculous serous effusion and screening for coinfections [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 335-341. |
| [6] | Jiao Xiaoke, Tian Yuan, Xiang Jingling, Nie Wenjuan, Pang Yu, Wang Jing. Analysis of factors influencing disability and mortality in HIV-negative tuberculous meningitis patients from 2011 to 2023 [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 342-348. |
| [7] | Wei Liuying, Wu Xingxing, Huang Lianpiao, Zeng Chunmei, Zhao Chunyan, Song Chang, Nie Wenjuan, Pei Jie, Wei Xiaoying, Huang Aichun, Zhu Qingdong, Xie Zhouhua, Huang Xianzhen. Analysis of the application effect of compound balanced nutrition powder in anti-tuberculosis treatment on multidrug-resistant tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 349-355. |
| [8] | Xu Liang, Dai Enuo, Yang Yongrui, Ruan Wenkai, Li Jianlong, Dang Rongpan, An Huigang, Zhao Wentao, Li Zhaofei, Zhao Yingxin, Li Ying, Sun Jianmin, Tan Hongdong. Observation on the effect of traditional Chinese medicine syndrome differentiation and treatment combined with standard anti-tuberculosis regimen on postoperative rehabilitation in patients with spinal tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 356-365. |
| [9] | Gao Yan, Peng Yingjie, Ge Xiao, Xu Jian, Liu Xiaohua, Liu Jinlong, Wang Yuanyuan. Screening and identification of iron death-related gene MT1G in tuberculosis based on bioinformatics [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 366-376. |
| [10] | Guo Huixin, Wu Zhuhua, Chen Yanmei, Yu Meiling, Peng Kehao, Xu Liuyue, Zhang Jianhui, Chen Xunxun. Investigation and analysis of biosafety status in tuberculosis laboratories of 138 tuberculosis prevention and control institutions in Guangdong Province [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 386-393. |
| [11] | Cao Hong, Qian Bing, Zhao Kefu, Chen Lili, He Yuqin, Wu Jinju, Chen Shuangshuang, Xu Rui, Zhao Cunxi. Analysis of characteristics of pulmonary tuberculosis patients aged 60 and above in Hefei City, 2015—2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 394-404. |
| [12] | Zhang Jian, Chen Bin, Zhang Mingwu, Qin Jiasheng, Song Yufang, Li Xuejing, Wang Wei. Analysis of the dynamics and influencing factors of latent tuberculosis infection in a rural elderly population in Changxing County [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 405-412. |
| [13] | Meng Qiuyue, Rong Ningning, Liu Yadong, Yang Haixia, Ma Mingli. Progress in interventions to improve treatment adherence among patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 413-418. |
| [14] | Pharmaceutical Professional Branch of Chinese Antituberculosis Association. Expert consensus on therapy and drug monitoring clinical application of anti-tuberculosis drug (updated in 2025) [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 167-187. |
| [15] | Fu Xuwen, He Weiyaozhen, Li Xiang. Imaging manifestations of male reproductive system tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 188-196. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.